Inflammatory Bowel Disease Treatment Market Scope And Analysis

  • Report Code : TIPRE00003491
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Inflammatory Bowel Disease Treatment Market - Scope 2031

Buy Now

Inflammatory Bowel Disease Treatment Market Report Inflammatory Bowel Disease Treatment Market Size and Share Inflammatory Bowel Disease Treatment Market Scope and Analysis

Inflammatory Bowel Disease Treatment Market Report Scope

Report Attribute Details
Market size in 2023 US$ 24.05 Billion
Market Size by 2031 US$ 31.67 Billion
Global CAGR (2023 - 2031) 3.50%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Drug Class
  • Aminosalicyclates
  • Immunomodulators
  • TNF Inhibitors
  • Corticosteroids
By Indication
  • Crohn's Disease
  • Ulcerative Colitis
By Distribution Channel
  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Pfizer Inc
  • Novartis AG
  • AbbVie Inc
  • Takeda Pharmaceuticals Johnson and Johnson
  • Celegene Corporation
  • Bausch Health Companies
  • UCB Inc
  • Cosmo Pharmaceutic als
    		•